Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Pfizer starts Ibrance trials in early breast cancer

Pfizer starts Ibrance trials in early breast cancer HER2 receptor targeted by drugs such as Roche's Herceptin (trastuzumab).

European approval for Roche’s next-gen breast cancer drug

European approval for Roche’s next-gen breast cancer drug Roche's new oncology drug Perjeta (pertuzumab) has been approved by the European Commission to treat certain breast cancer patients when used in combination with its ageing drug Herceptin (trastuzumab). ... However, the high cost of Perjeta plus

Roche pharma sales strong for first half of 2015

Roche pharma sales strong for first half of 2015 Its ageing breast cancer drug Herceptin (trastuzumab) and multi-cancer licensed Avastin (bevacizumab) were both a close second, recording identical sales of CHF3.26bn, up 11% and 9% respectively. ... big-selling cancer drugs - most notably Herceptin -

Pharma deals in June 2015

Pharma deals in June 2015 Roche has two products approved in Europe, Herceptin SC and MabThera SC, and Baxter has HyQvia approved in the US and EU, which utilise the Halozyme approach. ... Herceptin SC and MabThera SC can be administered in approximately 5 minutes by sc injection

Roche maintains dominance as leading cancer drugmaker

Roche maintains dominance as leading cancer drugmaker This includes sales of its biggest-selling established medicines, including the blood cancer drug MabThera (rituximab), the multi-cancer licenced Avastin (bevacizumab) and breast cancer treatment Herceptin (trastuzumab), as well newer

[ Previous 5 results ] 13 14 15 16 17 18 19 20 21 22 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics